The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Patel Dinesh V Ph D since year 2005.
The trader's CIK number is 1120477.
At the time of the last reporting, Patel Dinesh V Ph D was the President and CEO of Protagonist Therapeutics, Inc .
(stock ticker symbol PTGX).
See this page for all insider trading activities at Protagonist Therapeutics, Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-12-03||PTGX||Protagonist Therapeutics, Inc||Buy||30,000||5.60||168,000|
|2019-11-26||PTGX||Protagonist Therapeutics, Inc||Option Ex||4,000||1.16||4,640|
|2019-08-06||PTGX||Protagonist Therapeutics, Inc||Sale||10,792||8.85||95,530|
|2019-03-01||PTGX||Protagonist Therapeutics, Inc||Sale||2,183||8.03||17,529|
|2019-02-06||PTGX||Protagonist Therapeutics, Inc||Sale||10,909||7.90||86,224|
|2019-01-11||PTGX||Protagonist Therapeutics, Inc||Option Ex||22,344||1.16||25,919|
|2018-05-10||PTGX||Protagonist Therapeutics, Inc||Option Ex||13,516||1.16||15,678|
|2018-04-02||PTGX||Protagonist Therapeutics, Inc||Option Ex||20,000||1.16||23,200|
|2018-03-26||PTGX||Protagonist Therapeutics, Inc||Option Ex||11,298||.87||9,829|
|2017-12-21||PTGX||Protagonist Therapeutics, Inc||Option Ex||8,210||1.89||15,516|
|2017-12-21||PTGX||Protagonist Therapeutics, Inc||Sale||8,210||19.56||160,571|
|2017-12-20||PTGX||Protagonist Therapeutics, Inc||Option Ex||1,790||1.89||3,383|
|2017-12-20||PTGX||Protagonist Therapeutics, Inc||Sale||1,790||19.55||34,987|
|2017-05-09||PTGX||Protagonist Therapeutics, Inc||Option Ex||19,099||1.16||22,154|
|2017-04-06||PTGX||Protagonist Therapeutics, Inc||Option Ex||20,000||1.16||23,200|
|2017-03-10||PTGX||Protagonist Therapeutics, Inc||Option Ex||16,362||.87||14,234|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Patel Dinesh V Ph D (President and CEO of Protagonist Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.